172
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Optic Nerve Head Parameters and Peripapillary Retinal Nerve Fiber Layer Thickness in Patients with Coronavirus Disease 2019

, MD, MSc, , MD, MSc, , MSc, , MSc & , PharmD, PhD
Pages 1035-1038 | Received 27 Sep 2020, Accepted 09 Nov 2020, Published online: 19 Feb 2021

References

  • Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179–2184. doi:10.1007/s00415-020-09929-7. [published Online First: Epub Date].
  • Liu MY, Zheng B, Zhang Y, Li JP. Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019. Chronic Dis Transl Med. 2020;6(2):98–105. doi:10.1016/j.cdtm.2020.05.003.
  • Choudhary R, Kapoor MS, Singh A, Bodakhe SH. Therapeutic targets of renin-angiotensin system in ocular disorders. J Curr Ophthalmol. 2017;29(1):7–16. doi:10.1016/j.joco.2016.09.009.
  • Hollo G, Zhou Q. Evaluation of retinal nerve fiber layer thickness and ganglion cell complex progression rates in healthy, ocular hypertensive, and glaucoma eyes with the avanti RTVue-XR optical coherence tomograph based on 5-year follow-up. J Glaucoma. 2016;25(10):e905–e09. doi:10.1097/IJG.0000000000000410. [published Online First: Epub Date].
  • Cabrera DeBuc D, Gaca-Wysocka M, Grzybowski A, Kanclerz P. Identification of retinal biomarkers in Alzheimer’s disease using optical coherence tomography: recent insights, challenges, and opportunities. J Clin Med. 2019;8(7):996. doi:10.3390/jcm8070996. [published Online First: Epub Date].
  • Pietroboni AM, Carandini T, Dell’Arti L, et al. Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study. Neurol Sci. 2020;41(11):3175–3183. doi:10.1007/s10072-020-04431-4. [published Online First: Epub Date].
  • Salvi L, Plateroti P, Balducci S, et al. Abnormalities of retinal ganglion cell complex at optical coherence tomography in patients with type 2 diabetes: a sign of diabetic polyneuropathy, not retinopathy. J Diabetes Complications. 2016;30(3):469–476. doi:10.1016/j.jdiacomp.2015.12.025.
  • Pons-Escoda A, Naval-Baudin P, Majos C, et al. Neurologic Involvement in COVID-19: cause or coincidence? A neuroimaging perspective. AJNR Am J Neuroradiol. 2020;41(8):1365–1369. doi:10.3174/ajnr.A6627.
  • Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020;413:116832. doi:10.1016/j.jns.2020.116832.
  • Gklinos P. Neurological manifestations of COVID-19: a review of what we know so far. J Neurol. 2020;267(9):2485–2489. doi:10.1007/s00415-020-09939-5.
  • Abrishami M, Tohidinezhad F, Daneshvar R, et al. Ocular manifestations of hospitalized patients with COVID-19 in Northeast of Iran. Ocul Immunol Inflamm. 2020;28(5):739–744. doi:10.1080/09273948.2020.1773868.
  • Poustchi H, Eghtesad S, Kamangar F, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647–655. doi:10.1093/aje/kwx314.
  • Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R Jr. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi:10.1016/S0140-6736(20)31014-X.
  • Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94(7). doi:10.1128/JVI.00127-20.
  • Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637. doi:10.1002/path.1570.
  • Lahiri D, Mondal R, Deb S, et al. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: summarizing the evidences. Diabetes Metab Syndr. 2020;14(5):1053–1060. doi:10.1016/j.dsx.2020.06.062.
  • Kanberg N, Ashton NJ, Andersson LM, et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95(12):e1754–e1759. doi:10.1212/WNL.0000000000010111.
  • Su XW, Palka SV, Rao RR, Chen FS, Brackney CR, Cambi F. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia. Muscle Nerve. 2020;62(2):E48–E49. doi:10.1002/mus.26988.
  • Fernandez-Dominguez J, Ameijide-Sanluis E, Garcia-Cabo C, Garcia-Rodriguez R, Mateos V. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19). J Neurol. 2020;267(9):2495–2496. doi:10.1007/s00415-020-09912-2.
  • Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:10.1080/09273948.2020.1738501.
  • Burgos-Blasco B, Guemes-Villahoz N, Donate-Lopez J, Vidal-Villegas B, Garcia-Feijoo J. Optic nerve analysis in COVID-19 patients. J Med Virol. 2020. doi:10.1002/jmv.26290.
  • van den Pol AN. Viral infections in the developing and mature brain. Trends Neurosci. 2006;29(7):398–406. doi:10.1016/j.tins.2006.06.002.
  • Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41(10):2657–2669. doi:10.1007/s10072-020-04575-3.
  • Kim JE, Heo JH, Kim HO, et al. Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol. 2017;13(3):227–233. doi:10.3988/jcn.2017.13.3.227.
  • Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268–2270. doi:10.1056/NEJMc2008597.
  • Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi:10.1001/jamaneurol.2020.1127.
  • Correia AO, Feitosa PWG, Moreira JLS, Nogueira SÁR, Fonseca RB, Nobre MEP. Neurological manifestations of COVID-19 and other coronaviruses: a systematic review. Neurol Psychiatry Brain Res. 2020;37:27–32. doi:10.1016/j.npbr.2020.05.008.
  • Carignan A, Valiquette L, Grenier C, et al. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study. CMAJ. 2020;192(26):E702–E707. doi:10.1503/cmaj.200869.
  • Gupta S, Zivadinov R, Ramanathan M, Weinstock-Guttman B. Optical coherence tomography and neurodegeneration: are eyes the windows to the brain? Expert Rev Neurother. 2016;16(7):765–775. doi:10.1080/14737175.2016.1180978.
  • Lambe J, Murphy OC, Saidha S. Can optical coherence tomography be used to guide treatment decisions in adult or pediatric multiple sclerosis? Curr Treat Options Neurol. 2018;20(4):9. doi:10.1007/s11940-018-0493-6. Published 2018 Mar 21.
  • Miller N, Drachman DA. The optic nerve: a window into diseases of the brain? Neurology. 2006;67(10):1742–1743. doi:10.1212/01.wnl.0000250233.41910.2f.
  • Jenkins TM, Toosy AT. Optic neuritis: the eye as a window to the brain. Curr Opin Neurol. 2017;30(1):61–66. doi:10.1097/WCO.0000000000000414.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.